Difference between revisions of "Part:BBa K3096015"
m |
m |
||
Line 8: | Line 8: | ||
===Sequence and Features=== | ===Sequence and Features=== | ||
<partinfo>BBa_K3096015 SequenceAndFeatures</partinfo> | <partinfo>BBa_K3096015 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | ===Characterisation by iGEM Tuebingen 2019=== | ||
+ | Team iGEM Tuebingen 2019 has added and characterised pVEC by building a software tool which evaluates the penetrability of CPPs, comparing their activity. The results of the characterisation are shown in Fig. 1, where common or new CPPs are shown with their respective penetrability. | ||
+ | |||
Revision as of 06:12, 17 October 2019
pVEC - a cell penetrating peptide
pVEC (peptide vascular endothelial-cadherin) is a cell-penetrating peptide, which transports proteins through coadministration.
Contents
Biology & Usage
It is derived from a segment of the transmembrane domain part of a murine vascular endothelial-cadherin protein, which is involved in cell-cell adhesion. Its ability to enter the cell can mostly be explained by the N-terminal stretch of hydrophobic amino acids, which interact with the plasma membrane.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Characterisation by iGEM Tuebingen 2019
Team iGEM Tuebingen 2019 has added and characterised pVEC by building a software tool which evaluates the penetrability of CPPs, comparing their activity. The results of the characterisation are shown in Fig. 1, where common or new CPPs are shown with their respective penetrability.
References
- Kamei, Noriyasu, et al. "Usefulness of cell-penetrating peptides to improve intestinal insulin absorption." Journal of Controlled Release 132.1 (2008): 21-25.
- Elmquist, Anna, Mats Hansen, and Ülo Langel. "Structure–activity relationship study of the cell-penetrating peptide pVEC." Biochimica et Biophysica Acta (BBA)-Biomembranes 1758.6 (2006): 721-729.